Hydrogels for neuroprotection and functional rewiring: a new era for brain engineering
Rocío Fernandez-Serra1, Rebeca Gallego1, Paloma Lozano1
1Center for Biomedical Technology, Universidad Politécnica de Madrid, Madrid, Spain.
Neural Regeneration Research
|November 14, 2019
Summary
Hydrogel biomaterials offer advanced therapies for brain diseases like stroke and Alzheimer's. These materials improve drug delivery, cell survival, and nerve regeneration, addressing critical unmet needs in neuroprotection.
Area of Science:
- Biomaterials Science
- Neuroscience
- Regenerative Medicine
Background:
- Neurodegenerative and cerebrovascular diseases lack effective treatments, despite promising preclinical results.
- Current therapies fail to neuroprotect, halt degeneration, or rewire brain circuits.
- Challenges include inadequate models, unclear mechanisms, and poor drug/cell delivery systems.
Purpose of the Study:
- To review hydrogel-based biomaterials for treating brain pathologies.
- To highlight their impact on drug delivery, cell engraftment, and axonal reinnervation.
- To explore advanced therapeutic strategies for central nervous system disorders.
Main Methods:
- Review of current trends in hydrogel-based biomaterials for neurological applications.
- Analysis of hydrogel properties relevant to central nervous system tissue.
- Examination of hydrogel applications in drug delivery and cell transplantation.
Main Results:
- Hydrogels mimic cerebral tissue properties, suitable for drug and cell implantation.
- Three-dimensional hydrogel constructs can guide axonal growth.
- Hydrogels provide controlled drug release and enhance cell survival and function.
Conclusions:
- Hydrogel-based biomaterials represent a significant advancement in treating brain disorders.
- They offer improved control over drug delivery, cell engraftment, and neural repair.
- This approach holds promise for future neuroregenerative therapies.
